In the expansive and meticulously regulated landscape of pharmaceutical manufacturing, every component plays a pivotal role in ensuring the safety and efficacy of the final medicinal product. Among these crucial elements are pharmaceutical intermediates, chemical compounds that serve as indispensable building blocks in the synthesis of Active Pharmaceutical Ingredients (APIs). One such significant compound is 4,5-Dichloro-o-phenylenediamine, identified by its CAS number 5348-42-5, a vital ingredient used in complex organic synthesis processes by leading manufacturers like NINGBO INNO PHARMCHEM CO.,LTD.
Pharmaceutical intermediates are not the end product in themselves, nor do they possess the therapeutic effects of APIs. Instead, they are the essential 'semi-finished products' that undergo a series of chemical transformations to eventually yield the active component of a drug. Their importance lies in streamlining the intricate synthesis process, allowing for precise control over molecular structures and ensuring the purity and consistency required for high-quality APIs. This meticulous approach in manufacturing these intermediates is foundational to modern drug development and production.
4,5-Dichloro-o-phenylenediamine (CAS: 5348-42-5) stands out as a critical raw material in various organic synthesis applications, particularly within the pharmaceutical sector. This compound, appearing as a red-brown to brown crystalline powder, possesses distinct chemical properties that make it highly valuable. With a molecular formula of C6H6Cl2N2 and a molecular weight of 177.03100, it exhibits specific melting and boiling points (158-164 °C and 346.3 °C respectively), indicative of its stability under normal temperature and pressure. Ensuring a purity level of at least 95% is paramount for its effective use in subsequent reactions, preventing unwanted side products and maintaining the integrity of the final API.
The role of pharmaceutical intermediates like 4,5-Dichloro-o-phenylenediamine extends beyond mere chemical reactions; they are fundamental to drug innovation and cost-effective production. By enabling the breakdown of complex API synthesis into manageable steps, intermediates facilitate rigorous quality control at multiple checkpoints. This staged approach not only enhances efficiency but also significantly reduces the risk of impurities, which could compromise the safety and therapeutic efficacy of medications. For instance, high-quality intermediates are crucial in developing APIs for a wide array of therapeutic areas, including antibiotics, cardiovascular drugs, and anticancer agents, where precision and purity are non-negotiable.
The global demand for high-quality pharmaceutical intermediates continues to grow, driven by the increasing prevalence of chronic diseases and the rapid pace of pharmaceutical research and development. Manufacturers are constantly seeking reliable suppliers who can provide these essential compounds in bulk or as custom intermediates, meeting stringent specifications. The production of pharmaceutical intermediates, while not subject to the same strict drug licensing regulations as APIs, still requires profound expertise in organic chemistry, advanced manufacturing processes, and robust quality assurance systems. These include sophisticated analytical techniques such as Infrared spectroscopy (FTIR), Nuclear Magnetic Resonance (1H NMR), and Mass Spectrometry (MS) to verify composition and purity.
For companies looking to purchase high-quality 4,5-Dichloro-o-phenylenediamine (CAS: 5348-42-5) or other organic synthesis intermediates, selecting a reputable manufacturer is crucial. NINGBO INNO PHARMCHEM CO.,LTD. prides itself on its capability to produce and supply a diverse range of chemical products, ensuring exceptional quality and consistent supply. Whether you need to buy in small quantities for research or require bulk orders for large-scale production, a trusted supplier can provide competitive price options and efficient logistics. This commitment to quality and supply chain reliability underscores the importance of these 'intermediate' steps in bringing life-saving drugs to market, accelerating drug development, and ensuring that healthcare professionals and patients have access to the highest standard of pharmaceutical products.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.